XML 37 R24.htm IDEA: XBRL DOCUMENT v3.19.2
Note 3 - Restatement of Previously Issued Financial Statements and Adoption of New Accounting Standards (Tables)
 12 Months Ended
Sep. 29, 2018
Notes Tables  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
      As reported       Adjustment       As adjusted  
Balance Sheet                        
Deferred revenue   $
-
     $
484,121
     $
484,121
  
Accumulated deficit    
(822,636
 )    
(484,121
 )    
(1,306,757
 )
                         
Statement of Operations                        
Net revenue   $
4,209,127
     $
(484,121
 )   $
3,725,006
  
Gross profit    
2,291,237
      
(484,121
 )    
1,807,116
  
Operating loss    
(1,437,505
 )    
(484,121
 )    
(1,921,626
 )
Net loss    
(1,429,006
 )    
(484,121
 )    
(1,913,127
 )
Net loss per common share                        
Basic    
(0.78
 )    
(0.26
 )    
(1.04
 )
Diluted    
(0.78
 )    
(0.26
 )    
(1.04
 )
                         
Statement of cash flows                        
Net loss   $
(1,429,006
 )   $
(484,121
 )   $
(1,913,127
 )
Changes in current assets and current liabilities –                        
Deferred revenue    
-
      
484,121
      
484,121
  
                         
Statements of Changes in Stockholders' Equity                        
Accumulated deficit                        
Net loss   $
(1,429,006
 )   $
(484,121
 )   $
(1,913,127
 )
Ending balance    
(822,636
 )    
(484,121
 )    
(1,306,757
 )
Total stockholders’ equity    
3,500,354
      
(484,121
 )    
3,016,233
  
                         
Footnote 10 Income Taxes                        
Reconciliation of statutory federal income tax rate:                        
Tax expense (benefit) at U.S. statutory rate   $
(485,862
 )   $
(164,601
 )   $
(650,463
 )
State income tax provision, net of federal benefit    
(81,630
 )    
(23,370
 )    
(105,000
 )
Valuation allowance    
613,050
      
187,970
      
801,020
  
                         
Deferred income taxes:                        
Deferred revenue    
-
      
187,970
      
187,970
  
Valuation allowance   $
(4,723,406
 )   $
(187,970
 )   $
(4,911,376
 )
 
 
 
As reported
 
 
 
Adjustment
 
 
 
As adjusted
 
Statement of Cash Flows
 
 
 
 
 
 
 
 
 
 
 
 
Decrease in restricted cash
 
$
14,662
 
 
$
(14,662
)
 
$
-
 
Cash provided by investing activities
 
 
436,904
 
 
 
(14,662
)
 
 
422,242
 
Net decrease in cash, cash equivalents and restricted cash
 
 
(1,305,363
)
 
 
(14,662
)
 
 
(1,320,025
)
Cash, cash equivalents and restricted cash as of the beginning of the year
 
 
2,589,036
 
 
 
27,592
 
 
 
2,616,628
 
Cash, cash equivalents and restricted cash as of the end of the year
 
 
1,283,673
 
 
 
12,930
 
 
 
1,296,603